Bruns Ingmar (CIK 1838041) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-10). Recent activity: Sell ZNTL (2,962 shares), Sell ZNTL (335 shares), Buy ZNTL (20,000 shares), Buy ZNTL (16,629 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-10 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Chief Medical Officer | Sell | 2,962 | $7,198 |
| 2026-02-10 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Chief Medical Officer | Sell | 335 | $801 |
| 2025-02-12 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Chief Medical Officer | Buy | 20,000 | $45,600 |
| 2025-02-05 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Chief Medical Officer | Buy | 16,629 | $0 |
Source: SEC Form 4 filings · as of 2026-02-10